within Pharmacolibrary.Drugs.ATC.A;

model A10AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 5.3e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 720
  );

  annotation(Documentation(
    info ="<html><body><p>Insulin (human) is a peptide hormone used for the treatment of diabetes mellitus to control blood glucose levels. It is a replacement for endogenous insulin in patients with type 1 diabetes and is also used in type 2 diabetes when oral therapies are inadequate. It is approved for use worldwide and administered via subcutaneous, intravenous, or intramuscular routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (males and females), with subcutaneous administration of regular human insulin.</p><h4>References</h4><ol><li><p>Nishimura, E, et al., &amp; Haahr, H (2021). Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing. <i>BMJ open diabetes research &amp; care</i> 9(1) –. DOI:<a href=&quot;https://doi.org/10.1136/bmjdrc-2021-002301&quot;>10.1136/bmjdrc-2021-002301</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34413118/&quot;>https://pubmed.ncbi.nlm.nih.gov/34413118</a></p></li><li><p>Ma, X, et al., &amp; Leishman, D (2022). Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements. <i>Journal of diabetes science and technology</i> 16(2) 401–407. DOI:<a href=&quot;https://doi.org/10.1177/1932296820972719&quot;>10.1177/1932296820972719</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33242998/&quot;>https://pubmed.ncbi.nlm.nih.gov/33242998</a></p></li><li><p>Brogden, RN, &amp; Heel, RC (1987). Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. <i>Drugs</i> 34(3) 350–371. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198734030-00003&quot;>10.2165/00003495-198734030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3315622/&quot;>https://pubmed.ncbi.nlm.nih.gov/3315622</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10AC01;
